Guidance for West Pharmaceutical Services, Inc. (WST)
Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
---|---|---|---|---|---|---|
2024 | $7.50 – $7.75 | $8.78 | $3.00M – 3.03M | $3.21M | = Maintained | Details |
2023 | $7.25 – $7.40 | $7.27 | $2.94M – 2.96M | $2.87M | = Maintained | Details |
2022 | $9.30 – $9.45 | $9.28 | N/A | N/A | Raised | Details |
2022 | $9.20 – $9.35 | $9.06 | $3.05B – 3.08B | $3.07B | = Maintained | Details |
2022 | $9.00 – $9.12 | $9.32 | N/A | N/A | Lowered | Details |
2022 | N/A | N/A | $2.83B – 2.84B | $2.98B | = Maintained | Details |
2021 | $6.95 – $7.10 | $6.15 | $2.63B – 2.66B | $2.58B | = Maintained | Details |
2021 | $6.00 – $6.15 | $5.12 | $2.50B – 2.53B | $2.35B | = Maintained | Details |
2021 | $8.05 – $8.20 | $7.14 | $2.76M – 2.79M | $2.68M | Raised | Details |
2021 | $8.40 – $8.50 | $8.21 | $2.80B – 2.81B | $2.80B | = Maintained | Details |
2020 | $3.45 – $3.55 | $3.46 | $1.95B – 1.97B | $1.95B | = Maintained | Details |
2020 | $3.52 – $3.62 | $3.39 | $1.95B – 1.97B | $1.94B | = Maintained | Details |
2020 | $4.50 – $4.55 | $4.25 | $2.10B – 2.11B | $2.05B | = Maintained | Details |
2020 | $4.15 – $4.25 | $3.64 | $2.04B – 2.06B | $1.97B | = Maintained | Details |
2019 | $2.80 – $2.90 | $2.86 | $1.80M – 1.82M | $1.81M | = Maintained | Details |
2019 | $2.77 – $2.89 | $3.12 | N/A | N/A | = Maintained | Details |
2019 | $3.00 – $3.10 | $2.89 | $1.81M – 1.83M | $1.81M | = Maintained | Details |
2019 | $3.10 – $3.15 | $3.06 | $1.82B – 1.83B | $1.81B | = Maintained | Details |
2018 | $2.80 – $2.90 | $2.83 | $1.72M – 1.73M | $1.72M | = Maintained | Details |
2018 | $2.80 – $2.90 | $2.82 | $1.72B – 1.73B | $1.73B | = Maintained | Details |
Q3 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
2017 | $2.74 – $2.79 | $2.67 | $1.60B – 1.61B | $1.59B | = Maintained | Details |
Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
2016 | $2.10 – $2.25 | $2.15 | N/A | N/A | = Maintained | Details |
2016 | $2.12 – $2.25 | $2.18 | $1.49B – 1.51B | $1.50B | Raised | Details |
2016 | $2.17 – $2.22 | $2.21 | $1.51B – 1.52B | $1.51B | Raised | Details |
2016 | $2.15 – $2.25 | $2.21 | $1.51B – 1.52B | $1.50B | Raised | Details |
2015 | $1.74 – $1.92 | $1.97 | $1.43B – 1.46B | $1.48B | = Maintained | Details |
2015 | $1.69 – $1.84 | $1.84 | N/A | N/A | = Maintained | Details |
2015 | $1.74 – $1.84 | $1.80 | N/A | N/A | = Maintained | Details |
2015 | $1.79 – $1.84 | N/A | N/A | N/A | = Maintained | Details |
2014 | $1.75 – $1.89 | $1.87 | N/A | N/A | = Maintained | Details |
2014 | $1.77 – $1.82 | $1.82 | $1.41B – 1.44B | $1.44B | = Maintained | Details |
2013 | $2.97 – $3.17 | $3.00 | $1.36B – 1.40B | $1.32B | = Maintained | Details |
2013 | $3.05 – $3.20 | $3.13 | N/A | N/A | = Maintained | Details |
2013 | $3.10 – $3.25 | $3.14 | N/A | N/A | Raised | Details |
2012 | $2.37 – $2.55 | $2.51 | N/A | N/A | = Maintained | Details |
2012 | $2.50 – $2.67 | $2.49 | $1.25B – 1.28B | $1.23B | = Maintained | Details |
2012 | $2.67 – $2.72 | N/A | $1.25M – 1.27M | $1.25M | Raised | Details |
2011 | $2.25 – $2.45 | $2.41 | $1.14B – 1.17B | $1.16B | = Maintained | Details |
2011 | $2.30 – $2.50 | $2.35 | $1.16M – 1.19M | $1.16M | = Maintained | Details |
2011 | $2.30 – $2.40 | $2.38 | $1.17B – 1.20B | $1.18B | Lowered | Details |
2011 | $2.28 – $2.35 | $2.35 | $1.18B – 1.20B | $1.19B | = Maintained | Details |